This new report contains 897 pages and 7 tables.
The report is available by section, and can be customized to specific information needs and budget.
The report is available by section, and can be customized to specific information needs and budget.
The report presents a comprehensive analysis of the French hospital infectious disease testing market, including:
- Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.
- Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories.
- Instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of & leading suppliers by test.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako